Prof. MUDr. Sylvie Dusilová Sulková, DrSc.

Hemodialyzační středisko FN Hradec Králové

Je předsedkyní České nefrologické společnosti pro rok 2016-2018.

Prof. MUDr. Sylvie Dusilová Sulková, DrSc. je autorem těchto článků v časopise Postgraduální nefrologie:

Postgraduální nefrologie. 2017, roč. 15, č. 2, s. 23-25

Brandenburg VM, Evenepoel P, Floege J, et al., on behalf of ERA‑EDTA Working Group on CKD‑MBD and EUCALNET.
Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? Nephrol Dial
Transplant 2016;31:1211–1219.

Postgraduální nefrologie. 2016, roč. 14, č. 1, s. 13-14

Meyring‑Wosten A, Zhang H, Ye X, et al. Intradialytic hypoxemia and clinical outcomes in patients on hemodialysis. Clin J Am Soc Nephrol 2016; published on March 2; doi: 10.2215/CJN/08510815

Postgraduální nefrologie. 2015, roč. 13, č. 4, s. 52-54
Postgraduální nefrologie. 2015, roč. 13, č. 4, s. 63-64

Peters SAE, Bots ML, Canaud B, et al., on behalf of the HDF Pooling Project Investigators. Haemodiafiltration and mortality in end‑stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant 2015 Oct 22; doi:10.1093/ndt/gfv349 V posledních letech

Postgraduální nefrologie. 2015, roč. 13, č. 3, s. 42-44

Weir MA, Dixon SN, Fleet JL. β‑blocker dialyzability and mortality in older patients receiving hemodialysis. J Am Soc Nephrol 2015;26:987–996.

Postgraduální nefrologie. 2015, roč. 13, č. 2, s. 30-31

Laville M, Dorval M, Ros JF, Fay R, Cridlig J, Nortier JL, Juillard L, Debska‑Slizien A, Lorente LF, Thibaudin D, Granssen C, Schulz M, Moureau F, Loughraieb M, Rossignol P. Results of the HepZero study comparing heparin‑grafted membrane and standard care show that heparin‑grafted dialyser is safe and easy to use for heparin‑free dialysis. Kidney Int 2014;86:1260–1267.

Postgraduální nefrologie. 2014, roč. 12, č. 4, s. 58-60

Robinson BM, Zhang J, Morgenstern H, et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 2014;85:158—165.

Postgraduální nefrologie. 2014, roč. 12, č. 3, s. 43-44

Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol 2014. doi: 10.1681/ASN.2013101086

Postgraduální nefrologie. 2014, roč. 12, č. 2, s. 25-26

Vazquez E, Sanchez‑Perales C, Garcia‑Garcia F, et al. Sudden death in incident dialysis patients. Am J Nephrol 2014;39: 331–336.

Postgraduální nefrologie. 2014, roč. 12, č. 1, s. 1-4
Postgraduální nefrologie. 2013, roč. 11, č. 4, s. 60-61

Susantitaphong P, Siribamrungwonf M, Jaber B. Convective therapies versus low‑flux hemodialysis for chronic kidney failure: a meta‑analysis of randomized controlled trials. Nephrol Dial Transplant 2013; doi:10.1093/ndt/gft396

Postgraduální nefrologie. 2013, roč. 11, č. 3, s. 42-44

Jamal SA, Vandermeer B, Raggi P, et al. Effect of calcium‑based versus non‑calcium based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta‑analysis. Lancet 2013. Doi: org/10.1015/50140‑6736(13)60897‑1
Di Iorio B, Molony D, Bell C, et al: Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open‑label 24‑month randomized clinical trial. Am J Kidney Dis 2013. Doi: org/10.1053/j.ajkd.2013.03.023

Postgraduální nefrologie. 2012, roč. 10, č. 5, s. 74-76

Floege J, Raggi P, Block GA, et al. Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in hemodialysis patients. Nephrol Dial Transplant 2010;25:1916–1923.

Raggi P, Chertow GM, Urena‑Torres P, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low‑dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 2010;26:1327–1339.

Urena‑Torres P, Floege J, Hawley CM, et al: Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study. Nephrol Dial Transplant 2012, doi: 10.1093/ndt/gfs356

Postgraduální nefrologie. 2012, roč. 10, č. 4, s. 61-62

Harris TJ, Nazir R, Khetpal R, et al. Pain, sleep disturbances and survival in hemodialysis patients. Nephrol Dial Transplant 2012;27:758–765.

Postgraduální nefrologie. 2012, roč. 10, č. 2, s. 18-19
Postgraduální nefrologie. 2012, roč. 10, č. 1, s. 13-13

Westenfeld R, Schlieper G, Woltje M, et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis – implications for post‑transplant bone disease. Nephrol Dial Transplant 2011;26:4115–4123.

Postgraduální nefrologie. 2011, roč. 9, č. 6, s. 95-95

Kovesdy CP, Molnár MZ, Czira ME, et al. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate‑to‑advanced CKD. Nephron Clin Pract 2011;118:c78–c85.

Postgraduální nefrologie. 2011, roč. 9, č. 5, s. 79-81

Cejka D, Jager‑Lansky A, Kieweg H, et al. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 2011 May 25. [Epub ahead of print]

Cejka D, Herberth J, Branscum AJ, et al. Sclerostin and Dickkopf‑1 in renal osteodystrophy. Clin J Am Soc Nephrol 2011;6:877–882.

Postgraduální nefrologie. 2011, roč. 9, č. 3, s. 45-46

Farese S, Stauffer E, Kalicki R, et al. Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol 2011; 6:1447–1455.

Postgraduální nefrologie. 2011, roč. 9, č. 2, s. 29-30
Postgraduální nefrologie. 2010, roč. 8, č. 6, s. 86-87
Postgraduální nefrologie. 2010, roč. 8, č. 6, s. 97-98

Bernardo AP, Contesse SA, Bajo MA, Rodriques A, Del Peso G, Ossorio M, Cabrita A, Selgas R. Peritoneal membrane phosphate transport status: a cornerstone in phosphate handling in peritoneal dialysis. Clin J Am Soc Nephrol 2011; doi: 10.2215/CJN06960810

Postgraduální nefrologie. 2010, roč. 8, č. 5, s. 77-78

Floege J, Kim J, Ireland E, Chazot Ch, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Paslick‑Deetjen J, Schrenthaner G, Fouqueray B, Wheeler D on behalf of ARO investigators: Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant 2010; in print.

Postgraduální nefrologie. 2010, roč. 8, č. 4, s. 57-58

Block GA, Brillhart SL, Persky MS, Amer A, Slade AJ. Efficacy and safety of SBR759, a new iron-based phosphate binder. Kidney Int 2010;77:897–903.

Postgraduální nefrologie. 2010, roč. 8, č. 3, s. 40-41

Verdalles U, Abad S, Aragoncillo I, Millaverde M, Jofre R, Verde E, Vega A, Lopez-Gomez JM. Factors predicting mortality in elderly patients on dialysis. Nephron Clin Pract 2010;115:c28–c34.

Postgraduální nefrologie. 2010, roč. 8, č. 1, s. 13-14

DeLoach S, Joffe MM, Mai X, et al. Aortic calcification predict cardiovascular events and all-cause mortality in renal transplantation. Nephrol Dial Transplant 2009;24:1314–1319.

Postgraduální nefrologie. 2009, roč. 7, č. 6, s. 93-95

Navaro‑Gonzalez J, Mora‑Fernandez C, Muros M, Herrera H, Garcia J. Mineral metabolism and inflammation in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1646–1654.

Postgraduální nefrologie. 2009, roč. 7, č. 5, s. 74-75

Evenepoel P, van den Bergh B, Naesens M, de Jonge H, Mammens B, Claes K, Kuypers D, Vanrenterghem Y. Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 2009;4:665–672.

Postgraduální nefrologie. 2009, roč. 7, č. 5, s. 75-76

Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, BeddhuS. Weight loss interventions in chronic kidney disease: a systemic review and meta‑analysis. Clin J Am Soc Nephrol 2009; doi 10.2215/CJN.00250409.

Postgraduální nefrologie. 2009, roč. 7, č. 4, s. 57-58

Chan KE, Lazarus JM, Thadhani R, Hakim RM. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 2009;20:872–881.

Postgraduální nefrologie. 2009, roč. 7, č. 4, s. 58-60

Vazquez E, Sanchez‑Perales C, Garcia‑Garcia F, Castellano P, Garcia‑Cortes MJ, Liebana A, Lozeno C. Atrial fibrillation in incident dialysis patients. Kidney Int 2009;76:324–330.

Postgraduální nefrologie. 2009, roč. 7, č. 3, s. 37-38

Bradbury BD, Critchlow CW, Weir M et al. Impact of elevated C-reactive protein levels on erythropoiesis – stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Nephrol Dial Transplant 2009;24:919–925.

Postgraduální nefrologie. 2009, roč. 7, č. 3, s. 38-39

Jean G, Bresson E, Errat JC, et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. NephrolDial Transplant 2009;24:948–955.

Postgraduální nefrologie. 2009, roč. 7, č. 2, s. 28-29

Okša A, Spustová V, Krivošíková Z, Gazdíková K, Fedelešová V, Lajdová I, Štefíková K, Bernasovská G, Žilinská Z, Dzúrik R. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 2008;31:322–329.

Postgraduální nefrologie. 2009, roč. 7, č. 1, s. 13-14

Gutierrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359:584–592.

Postgraduální nefrologie. 2008, roč. 6, č. 3, s. 34-35
Postgraduální nefrologie. 2007, roč. 5, č. 6, s. 82-83
Postgraduální nefrologie. 2005, roč. 3, č. 6, s. 87-89

Panagua R, Amato D, Vonesh E, Guo A, Mujais S. Health-related quality of life predicts outcomes but is not affected by peritoneal clearance. The ADEMEX trial. Kidney Int 2005; 67:1093–1104.

Postgraduální nefrologie. 2005, roč. 3, č. 6, s. 89-90

Stenvinkel P, Wang K, Qureshi A, Axelson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Hogestrand T, Heimburger O, Holmes C, Challing M, Nordfors L. : Low fetuin A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005;67:2383–2392.

Postgraduální nefrologie. 2005, roč. 3, č. 5, s. 69-70

Nakanishi S, Kazama J, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Schigematsu T, Fugakawa M. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyreoidism in dialysis patients. Kidney Int 2005;67:1171-1178.

Postgraduální nefrologie. 2005, roč. 3, č. 5, s. 70-72

Tarek ME, Ohmit SE, McCullough PA, Crook ED, Brown WW, Grimm R, Bakris GL, Keane W, Flack JM. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency. The Kidney Early Evaluation Program. Kidney Int 2005;67:1483-1488.

Postgraduální nefrologie. 2005, roč. 3, č. 3, s. 37-38

Teng M, Wolf M, Ofsthun MN, Lazaru JM, Hernán MA, Camargo CA Jr, Thandhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115-1125.

Postgraduální nefrologie. 2005, roč. 3, č. 3, s. 38-40

Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Zouny EW. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44:661-671.

Postgraduální nefrologie. 2005, roč. 3, č. 2, s. 18-19

Gouva Ch, Nikolopoulos P, Ioannidis PA, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 2004;66:753–760.

Postgraduální nefrologie. 2005, roč. 3, č. 2, s. 19-20

Block A, Martin KJ, de Francisco ALM, Turner S, et al. Cinacalcet hydrochloride for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516–1525.

Postgraduální nefrologie. 2005, roč. 3, č. 1, s. 13-14

Avesani CM, Draibe SA, Kamimura MA, Colugnati FAB, Cuppari L. Resting energy expenditure of chronic kidney disease patients. Influence of renal function and subclinical inflammation. Am J Kidney Dis 2004;44:1008–1016.

Postgraduální nefrologie. 2005, roč. 3, č. 1, s. 14-16

Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44(Suppl 2):S34–S38.

Postgraduální nefrologie. 2004, roč. 2, č. 6, s. 91-93

Sanchez C, Lopez-Barea F, Sanchez-Cabezudo S, Bajo A, Mate A, Martinez E, Selgas R for the Collaborators of the Multicentre Study Group. Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometdy. A randomized multicentre study. Nephrol Dial Transplant 2004;19:1587-1593.

Postgraduální nefrologie. 2004, roč. 2, č. 5, s. 69-71

Dember LM, Holmberg EF, Kaufman JS. Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int 2004;66:390-398.

Postgraduální nefrologie. 2004, roč. 2, č. 5, s. 71-73

Troidle L, Gorban.Brennan N, Kliger A, Finkelsterin FO: Continuous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial 2003;16:428-437.

Postgraduální nefrologie. 2004, roč. 2, č. 4, s. 50-51

Cunningham J, Sprague SM (on behalf of the Osteoporosis Work Ggroup): Osteoporosis in chronic kidney disease. Am J Kidney Diseases 2004;43: 556-571.

Postgraduální nefrologie. 2004, roč. 2, č. 4, s. 51-53

Zayour D, Daouk M, Medawar W, et al. Predictors of bone mineral density in patiens on hemodialysis. Transpl Proc 2004;36:1297-1301.